• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Food>Food And Drug Administration

Food And Drug Administration

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results

    AcelRx Pharmaceuticals Provides Zalviso Regulatory Update and Reports First Quarter 2015 Financial Results

  2. Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines

    Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines

  3. Mylan Confirms First-to-File Patent Challenge Relating to Minivelle®

    Mylan Confirms First-to-File Patent Challenge Relating to Minivelle®

  4. J&J Changes 'Compassionate' Drug Use

    J&J Changes 'Compassionate' Drug Use

  5. Aetna to Stop Covering Routine Use of Power Morcellator--Update

    Aetna to Stop Covering Routine Use of Power Morcellator--Update

  6. Aetna to Stop Covering Routine Use of Morcellator

    Aetna to Stop Covering Routine Use of Morcellator

  7. Mylan Launches Generic Seasonale® Tablets

    Mylan Launches Generic Seasonale® Tablets

  8. GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations

    GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations

  9. Jubilant DraxImage Files Citizen Petition with the Food and Drug Administration (FDA )

    Jubilant DraxImage Files Citizen Petition with the Food and Drug Administration ( FDA )

  10. FDA Grants Fast Track Designation to Genzyme’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease

    FDA Grants Fast Track Designation to Genzyme’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.